Page last updated: 2024-12-08

nitroquine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitroquine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159929
CHEMBL ID49474
MeSH IDM0075598

Synonyms (14)

Synonym
ci 679
n(6)-((3,4-dichlorophenyl)methyl)- n(6)-nitroso-2,4,6-quinazolinetriamine
2,4,6-quinazolinetriamine, n(sup 6)-((3,4-dichlorophenyl)methyl)-n(sup 6)-nitroso-
2,4-diamino-6-((3,4-dichlorobenzyl)nitrosamino)quinazoline
nitroquine
quinazoline, 2,4-diamino-6-((3,4-dichlorobenzyl)nitrosamino)-
brn 0897689
ci-679
CHEMBL49474
22316-71-8
n-(2,4-diaminoquinazolin-6-yl)-n-[(3,4-dichlorophenyl)methyl]nitrous amide
2,4-diamino-6-[(3,4-dichlorobenzyl)-nitrosoamino]-quinazoline
n-[(3,4-dichlorophenyl)methyl]-n-(2,4-diimino-1,2,3,4-tetrahydroquinazolin-6-yl)nitrous amide
DTXSID90944964

Research Excerpts

Actions

ExcerptReferenceRelevance
"Nitroquine could inhibit the phospholipid synthesis and decrease the membrane fluidity of P. "( [Effect of nitroquine on the membrane phospholipid of intraerythrocytic Plasmodium yoelii in vitro].
Deng, S; Hu, Y, 1999
)
2.14
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID124556Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID124680Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 20 mg/kg; 2 survived after 60 days of postinfection1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID1146761Antimalarial activity against Plasmodium berghei infected in po dosed mouse assessed as suppression of parasitemia administered for 4 days1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
AID124704Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID124827Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 5 survived after 60 days of postinfection1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID124696Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg.1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID124705Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID124564Change in mean survival time of Trophozoite-induced Plasmodium berghei infected mice (Mus musculus) after 160 mg/kg subcutaneous dose; 60 days survival1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
AID124837Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (55.56)18.7374
1990's4 (22.22)18.2507
2000's2 (11.11)29.6817
2010's2 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.31 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.56%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]